Agreed - I'm certainly waiting to see what deals are realised off the back of the US patent. More broadly, research into exosomes continues to grow at an accelerating pace - which is positive for the pick and shovel play in Exopharm. I'd also note that EX1 is presenting at the Biotech Showcase, which is taking place over 10-12 Jan. Immugene and Radiopharm are also presenting there - will be interesting to see any company release on what will be presented.
Where has the chatter gone?, page-3
Add TYP (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
2.0¢ |
Change
0.000(0.00%) |
Mkt cap ! $20.69M | |||
| Open | High | Low | Value | Volume |
| 1.9¢ | 2.0¢ | 1.9¢ | $375 | 19.19K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 490202 | 2.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 2.1¢ | 125885 | 2 |
View Market Depth
| Last trade - 12.12pm 17/06/2024 (20 minute delay) ? |
|
|||||
|
Last
1.9¢ |
Change
0.000 ( 0.00 %) |
||||
| Open | High | Low | Volume | ||
| 1.9¢ | 1.9¢ | 1.9¢ | 4079 | ||
| Last updated 10.41am 17/06/2024 ? | |||||
| TYP (ASX) Chart |
